Biodesix to Participate in Upcoming Investor Conferences
Biodesix (NASDAQ: BDSX), a diagnostic solutions company, has announced its participation in two upcoming investor conferences. The company will attend the 22nd Annual Craig-Hallum Institutional Investor Conference for one-on-one meetings on May 28, 2025, in Minneapolis, MN. Additionally, Biodesix will present at the 45th Annual William Blair Growth Stock Conference on June 4, 2025, at 9:20 AM CT in Chicago, IL. The William Blair conference presentation will be available via webcast and can be accessed through the Investors section of Biodesix's website under \"News & Events\".
Biodesix (NASDAQ: BDSX), azienda specializzata in soluzioni diagnostiche, ha annunciato la sua partecipazione a due prossimi convegni per investitori. La societ脿 sar脿 presente al 22掳 Annuale Craig-Hallum Institutional Investor Conference per incontri individuali il 28 maggio 2025 a Minneapolis, MN. Inoltre, Biodesix presenter脿 al 45掳 Annuale William Blair Growth Stock Conference il 4 giugno 2025 alle 9:20 AM CT a Chicago, IL. La presentazione al convegno William Blair sar脿 disponibile in webcast e potr脿 essere seguita nella sezione Investitori del sito web di Biodesix, sotto la voce "News & Events".
Biodesix (NASDAQ: BDSX), una empresa de soluciones diagn贸sticas, ha anunciado su participaci贸n en dos pr贸ximas conferencias para inversores. La compa帽铆a asistir谩 a la 22陋 Conferencia Anual Craig-Hallum Institutional Investor para reuniones individuales el 28 de mayo de 2025 en Minneapolis, MN. Adem谩s, Biodesix presentar谩 en la 45陋 Conferencia Anual William Blair Growth Stock el 4 de junio de 2025 a las 9:20 AM CT en Chicago, IL. La presentaci贸n en la conferencia William Blair estar谩 disponible v铆a webcast y podr谩 accederse a ella a trav茅s de la secci贸n de Inversores en la p谩gina web de Biodesix, bajo "Noticias y Eventos".
Biodesix (NASDAQ: BDSX)電� 歆勲嫧 靻旊（靺� 須岇偓搿滌劀, 雼り皜鞓る姅 霊� 臧滌潣 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳棳頃� 鞓堨爼鞛勳潉 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 2025雲� 5鞗� 28鞚� 氙鸽劋靻岉儉欤� 氙鸽媹鞎犿彺毽姢鞐愳劀 鞐措Μ電� 鞝�22須� Craig-Hallum 旮瓣磤 韴瀽鞛� 鞐半 旎嵓霟办姢鞐愳劀 鞚茧寑鞚� 氙疙寘鞐� 彀胳劃頃╇媹雼�. 霕愴暅, Biodesix電� 2025雲� 6鞗� 4鞚� 鞓れ爠 9鞁� 20攵�(欷戨秬鞁滉皠) 鞚茧Μ雲胳澊欤� 鞁滌勾瓿犾棎靹� 臧滌禍霅橂姅 鞝�45須� William Blair 靹膘灔欤� 鞐半 旎嵓霟办姢鞐愳劀 氚滍憸頃� 鞓堨爼鞛呺媹雼�. William Blair 旎嵓霟办姢 氚滍憸電� 鞗轨簮鞀ろ姼搿� 鞝滉车霅橂┌, Biodesix 鞗轨偓鞚错姼鞚� 韴瀽鞛� 靹轨厴 雮� "雺挫姢 氚� 鞚措菠韸�"鞐愳劀 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
Biodesix (NASDAQ : BDSX), une entreprise sp茅cialis茅e dans les solutions diagnostiques, a annonc茅 sa participation 脿 deux prochaines conf茅rences pour investisseurs. La soci茅t茅 assistera 脿 la 22e conf茅rence annuelle Craig-Hallum Institutional Investor pour des r茅unions individuelles le 28 mai 2025 脿 Minneapolis, MN. De plus, Biodesix pr茅sentera lors de la 45e conf茅rence annuelle William Blair Growth Stock le 4 juin 2025 脿 9h20 CT 脿 Chicago, IL. La pr茅sentation lors de la conf茅rence William Blair sera disponible en webcast et accessible via la section Investisseurs du site web de Biodesix, sous "Actualit茅s & 脡v茅nements".
Biodesix (NASDAQ: BDSX), ein Unternehmen f眉r diagnostische L枚sungen, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen bekanntgegeben. Das Unternehmen wird am 22. j盲hrlichen Craig-Hallum Institutional Investor Conference am 28. Mai 2025 in Minneapolis, MN, f眉r Einzelgespr盲che teilnehmen. Zus盲tzlich wird Biodesix am 45. j盲hrlichen William Blair Growth Stock Conference am 4. Juni 2025 um 9:20 Uhr CT in Chicago, IL, pr盲sentieren. Die Pr盲sentation auf der William Blair Konferenz wird per Webcast verf眉gbar sein und kann 眉ber den Bereich "Investoren" auf der Biodesix-Website unter "News & Events" abgerufen werden.
- None.
- None.
LOUISVILLE, Colo., May 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that members of the Biodesix management team, will participate in two upcoming investor conferences:
22nd Annual Craig-Hallum Institutional Investor Conference
1x1 Meetings
Date: Wednesday, May 28, 2025
Location: Minneapolis, MN
45th Annual William Blair Growth Stock Conference
Presentation and 1x1 Meetings
Date and Time: Wednesday, June 4, 2025 at 9:20 AM CT
Location: Chicago, IL
The presentation will be webcast live and available for replay under 鈥淣ews & Events鈥� in the Investors section of the Company's website at .
About Biodesix
Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, marketed as Nodify Lung庐 Nodule Risk Assessment and IQLung鈩� Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world鈥檚 leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. For more information, visit聽.
Trademarks: Biodesix, Biodesix Logo, Nodify Lung, and IQLung are trademarks or registered trademarks of Biodesix, Inc.
Contacts:
Media:
Natalie St. Denis
1-720-925-9285
Investors:
Chris Brinzey
1-339-970-2843
FAQ
When is Biodesix (BDSX) presenting at the William Blair Growth Stock Conference 2025?
Where can I watch Biodesix's (BDSX) William Blair conference presentation?
Which investor conferences is Biodesix (BDSX) attending in 2025?
When is Biodesix (BDSX) participating in the Craig-Hallum Conference 2025?
